Creative Medical Technology Holdings, Inc. Basic Shares Outstanding (Weighted Average)
Creative Medical Technology Holdings, Inc. (CELZ) reported Basic Shares Outstanding (Weighted Average) of 10.93 million shares for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2023-03-31
- Creative Medical Technology Holdings, Inc. weighted average number of shares outstanding, basic for the quarter ending 2022-12-31 was 14.11M shares, a 305.34% increase year-over-year.
- Creative Medical Technology Holdings, Inc. weighted average number of shares outstanding, basic for the quarter ending 2022-09-30 was 14.07M shares, a 473.73% increase year-over-year.
- Creative Medical Technology Holdings, Inc. weighted average number of shares outstanding, basic for the quarter ending 2022-06-30 was 9.01M shares, a 288.40% increase year-over-year.
- Creative Medical Technology Holdings, Inc. weighted average number of shares outstanding, basic for the quarter ending 2022-03-31 was 6.45M shares, a 183.43% increase year-over-year.
- Creative Medical Technology Holdings, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 10.93M shares, a 319.65% increase from fiscal 2021.
- Creative Medical Technology Holdings, Inc. weighted average number of shares outstanding, basic for fiscal 2021 was 2.61M shares, a 349.57% increase from fiscal 2020.
- Creative Medical Technology Holdings, Inc. weighted average number of shares outstanding, basic for fiscal 2020 was 579.46K shares.
- Creative Medical Technology Holdings, Inc. weighted average number of shares outstanding, basic for fiscal 2015 was 18.11M shares, a 0.00% change from fiscal 2014.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|---|---|---|
| 2022-12-31 | 14.11M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | 14.09M shares derived: average of 2 quarters · filed 2023-03-31 | 12.40M shares derived: average of 3 quarters · filed 2023-03-31 | 10.93M shares 10-K · filed 2023-03-31 | |||
| 2022-09-30 | 14.07M shares 10-Q · filed 2022-11-10 | 11.54M shares derived: average of 2 quarters · filed 2022-11-10 | 9.87M shares 10-Q · filed 2022-11-10 | 8.25M shares derived: average of 4 quarters · filed 2023-03-31 | |||
| 2022-06-30 | 9.01M shares 10-Q · filed 2022-08-12 | 7.74M shares 10-Q · filed 2022-08-12 | 6.32M shares derived: average of 3 quarters · filed 2023-03-31 | 5.35M shares derived: average of 4 quarters · filed 2023-03-31 | |||
| 2022-03-31 | 6.45M shares 10-Q · filed 2022-05-13 | 4.97M shares derived: average of 2 quarters · filed 2023-03-31 | 4.13M shares derived: average of 3 quarters · filed 2023-03-31 | 3.68M shares derived: average of 4 quarters · filed 2023-03-31 | |||
| 2021-12-31 | 3.48M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | 2.97M shares derived: average of 2 quarters · filed 2023-03-31 | 2.75M shares derived: average of 3 quarters · filed 2023-03-31 | 2.61M shares 10-K · filed 2023-03-31 | |||
| 2021-09-30 | 2.45M shares 10-Q · filed 2022-11-10 | 2.39M shares derived: average of 2 quarters · filed 2022-11-10 | 2.31M shares 10-Q · filed 2022-11-10 | 2.06M shares derived: average of 4 quarters · filed 2022-11-10 | |||
| 2021-06-30 | 2.32M shares 10-Q · filed 2022-08-12 | 2.24M shares 10-Q · filed 2022-08-12 | 1.12B shares 10-Q · filed 2021-08-16 | 1.94M shares derived: average of 3 quarters · filed 2022-08-12 | 1.62M shares derived: average of 4 quarters · filed 2022-08-12 | ||
| 2021-03-31 | 2.28M shares 10-Q · filed 2022-05-13 | 1.14B shares 10-Q · filed 2021-05-17 | 1.74M shares derived: average of 2 quarters · filed 2022-05-13 | 1.39M shares derived: average of 3 quarters · filed 2022-05-13 | 43.33M shares derived: average of 4 quarters · filed 2022-05-13 | ||
| 2020-12-31 | 1.21M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | 947.28K shares derived: average of 2 quarters · filed 2022-03-30 | 57.02M shares derived: average of 3 quarters · filed 2022-03-30 | 579.46K shares 10-K · filed 2022-03-30 | |||
| 2020-09-30 | 684.98K shares 10-Q · filed 2021-11-15 | 342.49M shares 10-Q · filed 2020-11-13 | 84.92M shares derived: average of 2 quarters · filed 2021-11-15 | 369.42K shares 10-Q · filed 2021-11-15 | 184.71M shares 10-Q · filed 2020-11-13 | ||
| 2020-06-30 | 169.16M shares 10-Q · filed 2020-08-14 | 104.95M shares 10-Q · filed 2021-08-16 | |||||
| 2020-03-31 | 40.75M shares 10-Q · filed 2021-05-17 | ||||||
| 2019-09-30 | 1.51B shares 10-Q · filed 2020-11-13 | 759.50M shares derived: average of 2 quarters · filed 2020-11-13 | 1.18B shares 10-Q · filed 2020-11-13 | ||||
| 2019-06-30 | 7.10M shares 10-Q · filed 2020-08-14 | 6.77M shares 10-Q · filed 2020-08-14 | |||||
| 2019-03-31 | 6.44M shares 10-Q · filed 2020-05-15 | ||||||
| 2016-03-31 | 18.11M shares 10-Q · filed 2016-05-13 | 18.11M shares derived: average of 2 quarters · filed 2016-05-13 | 18.11M shares derived: average of 3 quarters · filed 2016-05-13 | 18.11M shares derived: average of 4 quarters · filed 2016-05-13 | |||
| 2015-12-31 | 18.11M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-14 | 18.11M shares derived: average of 2 quarters · filed 2016-04-14 | 18.11M shares derived: average of 3 quarters · filed 2016-04-14 | 18.11M shares 10-K · filed 2016-04-14 | |||
| 2015-09-30 | 18.11M shares 10-Q · filed 2015-11-09 | 18.11M shares derived: average of 2 quarters · filed 2015-11-09 | 18.11M shares 10-Q · filed 2015-11-09 | 18.11M shares derived: average of 4 quarters · filed 2016-05-13 | |||
| 2015-06-30 | 18.11M shares 10-Q · filed 2015-08-13 | 18.11M shares 10-Q · filed 2015-08-13 | 18.11M shares derived: average of 3 quarters · filed 2016-05-13 | 18.11M shares derived: average of 4 quarters · filed 2016-05-13 | |||
| 2015-03-31 | 18.11M shares 10-Q · filed 2016-05-13 | 18.11M shares derived: average of 2 quarters · filed 2016-05-13 | 18.11M shares derived: average of 3 quarters · filed 2016-05-13 | 18.11M shares derived: average of 4 quarters · filed 2016-05-13 | |||
| 2014-12-31 | 18.11M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-14 | 18.11M shares derived: average of 2 quarters · filed 2016-04-14 | 18.11M shares derived: average of 3 quarters · filed 2016-04-14 | 18.11M shares 10-K · filed 2016-04-14 | |||
| 2014-09-30 | 18.11M shares 10-Q · filed 2015-11-09 | 18.11M shares derived: average of 2 quarters · filed 2015-11-09 | 18.11M shares 10-Q · filed 2015-11-09 | 18.11M shares derived: average of 4 quarters · filed 2015-11-09 | |||
| 2014-06-30 | 18.11M shares 10-Q · filed 2015-08-13 | 18.11M shares 10-Q · filed 2015-08-13 | 18.11M shares derived: average of 3 quarters · filed 2015-08-13 | 18.11M shares derived: average of 4 quarters · filed 2015-08-13 | |||
| 2014-03-31 | 18.11M shares 10-Q · filed 2015-05-08 | 18.11M shares derived: average of 2 quarters · filed 2015-05-08 | 18.11M shares derived: average of 3 quarters · filed 2015-05-08 | 18.11M shares derived: average of 4 quarters · filed 2015-05-08 | |||
| 2013-12-31 | 18.11M shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | 18.11M shares derived: average of 2 quarters · filed 2015-02-27 | 18.11M shares derived: average of 3 quarters · filed 2015-02-27 | 18.11M shares 10-K · filed 2015-02-27 | |||
| 2013-09-30 | 18.11M shares 10-Q · filed 2014-11-12 | 18.11M shares derived: average of 2 quarters · filed 2014-11-12 | 18.11M shares 10-Q · filed 2014-11-12 | 18.11M shares derived: average of 4 quarters · filed 2014-11-12 | |||
| 2013-06-30 | 18.11M shares 10-Q · filed 2014-08-08 | 18.11M shares 10-Q · filed 2014-08-08 | 18.11M shares derived: average of 3 quarters · filed 2014-08-08 | 18.11M shares derived: average of 4 quarters · filed 2014-08-08 | |||
| 2013-03-31 | 18.11M shares 10-Q · filed 2014-05-13 | 18.11M shares derived: average of 2 quarters · filed 2014-05-13 | 18.11M shares derived: average of 3 quarters · filed 2014-05-13 | 18.11M shares derived: average of 4 quarters · filed 2014-05-13 | |||
| 2012-12-31 | 18.11M shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | 18.11M shares derived: average of 2 quarters · filed 2014-03-17 | 18.11M shares derived: average of 3 quarters · filed 2014-03-17 | 18.11M shares 10-K · filed 2014-03-17 | |||
| 2012-09-30 | 18.11M shares 10-Q · filed 2013-11-13 | 18.11M shares derived: average of 2 quarters · filed 2013-11-13 | 18.11M shares 10-Q · filed 2013-11-13 | ||||
| 2012-06-30 | 18.11M shares 10-Q · filed 2013-08-07 | 18.11M shares 10-Q · filed 2013-08-07 | |||||
| 2012-03-31 | 18.11M shares 10-Q · filed 2013-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |